Ryan M. Bartolucci Sells 339 Shares of Tempus AI, Inc. (NASDAQ:TEM) Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 339 shares of the company’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $40.23, for a total value of $13,637.97. Following the completion of the sale, the chief accounting officer now owns 71,007 shares of the company’s stock, valued at $2,856,611.61. This trade represents a 0.48 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Tempus AI Stock Performance

Shares of TEM stock opened at $33.03 on Friday. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69. The business’s 50-day simple moving average is $51.96. Tempus AI, Inc. has a fifty-two week low of $22.89 and a fifty-two week high of $79.49.

Hedge Funds Weigh In On Tempus AI

Hedge funds have recently made changes to their positions in the company. First Horizon Advisors Inc. acquired a new position in Tempus AI during the third quarter valued at $30,000. Sandia Investment Management LP purchased a new stake in shares of Tempus AI in the second quarter worth about $136,000. Vestor Capital LLC acquired a new position in Tempus AI in the third quarter valued at approximately $153,000. Stifel Financial Corp purchased a new position in shares of Tempus AI during the 3rd quarter valued at approximately $218,000. Finally, IQ EQ FUND MANAGEMENT IRELAND Ltd acquired a new position in shares of Tempus AI in the 3rd quarter valued at $258,000. 24.22% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on TEM shares. Piper Sandler restated a “neutral” rating and set a $70.00 target price (up previously from $40.00) on shares of Tempus AI in a research note on Tuesday, November 12th. Guggenheim assumed coverage on Tempus AI in a research report on Monday, December 9th. They set a “buy” rating and a $74.00 target price for the company. Bank of America raised their price objective on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Wolfe Research started coverage on Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 price target for the company. Finally, Loop Capital upped their price objective on Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a report on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $56.00.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.